1. Home
  2. ATRC vs BELFA Comparison

ATRC vs BELFA Comparison

Compare ATRC & BELFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • BELFA
  • Stock Information
  • Founded
  • ATRC 2000
  • BELFA 1949
  • Country
  • ATRC United States
  • BELFA United States
  • Employees
  • ATRC N/A
  • BELFA N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • BELFA
  • Sector
  • ATRC Health Care
  • BELFA
  • Exchange
  • ATRC Nasdaq
  • BELFA Nasdaq
  • Market Cap
  • ATRC 1.1B
  • BELFA 1.3B
  • IPO Year
  • ATRC 2005
  • BELFA N/A
  • Fundamental
  • Price
  • ATRC $35.34
  • BELFA $86.50
  • Analyst Decision
  • ATRC Strong Buy
  • BELFA
  • Analyst Count
  • ATRC 9
  • BELFA 0
  • Target Price
  • ATRC $41.78
  • BELFA N/A
  • AVG Volume (30 Days)
  • ATRC 465.9K
  • BELFA 10.0K
  • Earning Date
  • ATRC 02-13-2025
  • BELFA 02-19-2025
  • Dividend Yield
  • ATRC N/A
  • BELFA 0.29%
  • EPS Growth
  • ATRC N/A
  • BELFA N/A
  • EPS
  • ATRC N/A
  • BELFA 4.32
  • Revenue
  • ATRC $447,573,000.00
  • BELFA $524,943,000.00
  • Revenue This Year
  • ATRC $17.75
  • BELFA N/A
  • Revenue Next Year
  • ATRC $13.44
  • BELFA $0.77
  • P/E Ratio
  • ATRC N/A
  • BELFA $19.39
  • Revenue Growth
  • ATRC 17.56
  • BELFA N/A
  • 52 Week Low
  • ATRC $18.94
  • BELFA $51.00
  • 52 Week High
  • ATRC $39.05
  • BELFA $106.93
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 61.92
  • BELFA 40.48
  • Support Level
  • ATRC $31.00
  • BELFA $81.77
  • Resistance Level
  • ATRC $36.15
  • BELFA $92.44
  • Average True Range (ATR)
  • ATRC 1.50
  • BELFA 2.54
  • MACD
  • ATRC 0.55
  • BELFA -0.39
  • Stochastic Oscillator
  • ATRC 88.19
  • BELFA 45.27

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

About BELFA Bel Fuse Inc.

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

Share on Social Networks: